February 10, 2020
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is announcing a new Fiscal Year 2020 funding opportunity and Request for Applications to support the collection of data on antimicrobial use in dogs and cats. CVM has funded several ongoing studies to collect use data in food-producing animals and believes it is also important to collect data about the use of antimicrobial drugs in dogs and cats and how these use practices might contribute to the development of antimicrobial resistant bacteria.
As part of the agency’s 5-year plan for Supporting Antimicrobial Stewardship in Veterinary Settings, CVM will engage with stakeholders to develop and implement a strategy to promote the judicious use of medically important antimicrobials in companion animals. The data generated from this data collection effort will help inform this strategy.
Beginning on March 2, 2020, CVM will accept applications for the Fiscal Year (FY) 2020 Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats. CVM intends to fund up to $400,000 for FY 2020 in support of this program with an individual award maximum of $200,000. Up to four additional years of funding may be awarded based on available resources and satisfactory awardee performance.
Data collected through this cooperative agreement will support efforts to assess potential associations between antimicrobial use practices in dogs and cats and antimicrobial resistance. The data collected are also expected to provide information on data collection methodologies to help optimize long-term strategies for collection and reporting of antimicrobial use in dogs and cats.
- Funding Opportunity Announcement: Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats
- Supporting Antimicrobial Stewardship in Veterinary Settings: Goals for Fiscal Years 2019-2023
- Judicious Use of Antimicrobials
Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.